Two-step grafting significantly enhances the survival of foetal dopaminergic transplants and induces graft-derived vascularisation in a 6-OHDA model of Parkinson's disease

Neurobiology of Disease

Volumn 68, Issue , 2014, Pages 112-125

  Büchele, Fabian ^a,b   Döbrössy, Máté ^a   Hackl, Christina ^a,c   Jiang, Wei ^a,d   Papazoglou, Anna ^a,e   Nikkhah, Guido ^f  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e Federal Institute for Drugs and Medical Devices Cellular and Systemic Neurophysiology   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Cell survival; Cell transplantation; Graft derived angiogenesis; Parkinson's disease; Two step grafting

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; FEMALE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HISTOPATHOLOGY; NERVE TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; THERAPY EFFECT; TWO STEP GRAFTING; VASCULARIZATION; ANIMAL; ANIMAL EMBRYO; DIAGNOSTIC USE; DISEASE MODEL; GENETICS; INJURIES; LEWIS RAT; MEDIAL FOREBRAIN BUNDLE; METABOLISM; NERVE FIBER; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TIME; TRANSGENIC RAT; TRANSPLANTATION;

ADRENERGIC RECEPTOR STIMULATING AGENT; APOMORPHINE; DOPAMINE; GREEN FLUORESCENT PROTEIN; OXIDOPAMINE;

ADRENERGIC AGENTS; ANIMALS; APOMORPHINE; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINERGIC NEURONS; EMBRYO, MAMMALIAN; FEMALE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; MEDIAL FOREBRAIN BUNDLE; NERVE FIBERS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; TIME FACTORS;

EID: 84901019852     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.04.009     Document Type: Article

References (64)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 1946, 94:239-247.
2. Asada H., Ip N.Y., Pan L., Razack N., Parfitt M.M., Plunkett R.J. Time course of ciliary neurotrophic factor mRNA expression is coincident with the presence of protoplasmic astrocytes in traumatized rat striatum. J. Neurosci. Res. 1995, 40:22-30.
3. Baker-Cairns B.J., Sloan D.J., Broadwell R.D., Puklavec M., Charlton H.M. Contributions of donor and host blood vessels in CNS allografts. Exp. Neurol. 1996, 142:36-46.
4. Batchelor P.E., Liberatore G.T., Wong J.Y.F., Porritt M.J., Frerichs F., Donnan G.A., Howells D.W. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 1999, 19:1708-1716.
5. Björklund A., Stenevi U. Intracerebral neural implants: neuronal replacement and reconstruction of damaged circuitries. Annu. Rev. Neurosci. 1984, 7:279-308.
6. Brandis A., Kuder H., Knappe U., Jödicke A., Schönmayr R., Samii M., Walter G.F., Nikkhah G. Time-dependent expression of donor- and host-specific major histocompatibility complex class I and II antigens in allogeneic dopamine-rich macro- and micrografts: comparison of two different grafting protocols. Acta Neuropathol. 1998, 95:85-97.
7. Broadwell R.D., Charlton H.M., Ebert P.S., Hickey W.F., Shirazi Y., Villegas J., Wolf A.L. Allografts of CNS tissue possess a blood-brain barrier. II. Angiogenesis in solid tissue and cell suspension grafts. Exp. Neurol. 1991, 112:1-28.
8. Brundin P., Widner H., Nilsson O.G., Strecker R.E., Björklund A. Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier. Exp. Brain Res. 1989, 75:195-207.
9. Brundin P., Karlsson J., Emgård M., Schierle G.S., Hansson O., Petersén A., Castilho R.F. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 2000, 9:179-195.
10. Brundin P., Pogarell O., Hagell P., Piccini P., Widner H., Schrag A., Kupsch A., Crabb L., Odin P., Gustavii B., Björklund A., Brooks D.J., Marsden C.D., Oertel W.H., Quinn N.P., Rehncrona S., Lindvall O. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 2000, 123(Pt 7):1380-1390.
11. Casper D., Finkelstein E., Goldstein I.M., Palencia D., Yunger Y., Pidel A. Dopaminergic neurons associate with blood vessels in neural transplants. Exp. Neurol. 2003, 184:785-793.
12. Darsalia V., Allison S.J., Cusulin C., Monni E., Kuzdas D., Kallur T., Lindvall O., Kokaia Z. Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J. Cereb. Blood Flow Metab. 2011, 31:235-242.
13. Davies S.J., Fitch M.T., Memberg S.P., Hall A.K., Raisman G., Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 1997, 390:680-683.
14. Dunnett S.B., Björklund A., Stenevi U., Iversen S.D. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions. Brain Res. 1981, 229:457-470.
15. Dusart I., Nothias F., Roudier F., Besson J.M., Peschanski M. Vascularization of fetal cell suspension grafts in the excitotoxically lesioned adult rat thalamus. Brain Res. Dev. Brain Res. 1989, 48:215-228.
16. Finger S., Dunnett S.B. Nimodipine enhances growth and vascularization of neural grafts. Exp. Neurol. 1989, 104:1-9.
17. Ford M.C., Bertram J.P., Hynes S.R., Michaud M., Li Q., Young M., Segal S.S., Madri J.A., Lavik E.B. A macroporous hydrogel for the coculture of neural progenitor and endothelial cells to form functional vascular networks in vivo. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2512-2517.
18. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 2001, 344:710-719.
19. Ganser C., Papazoglou A., Just L., Nikkhah G. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures. Exp. Cell Res. 2010, 316:737-746.
20. Gates M.A., Dunnett S.B. The influence of astrocytes on the development, regeneration and reconstruction of the nigrostriatal dopamine system. Restor. Neurol. Neurosci. 2001, 19:67-83.
21. Gates M.A., Laywell E.D., Fillmore H., Steindler D.A. Astrocytes and extracellular matrix following intracerebral transplantation of embryonic ventral mesencephalon or lateral ganglionic eminence. Neuroscience 1996, 74:579-597.
22. Gundersen H.J., Bendtsen T.F., Korbo L., Marcussen N., Møller A., Nielsen K., Nyengaard J.R., Pakkenberg B., Sørensen F.B., Vesterby A. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988, 96:379-394.
23. Hansson O., Castilho R.F., Kaminski Schierle G.S., Karlsson J., Nicotera P., Leist M., Brundin P. Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons. Exp. Neurol. 2000, 164:102-111.
24. Hudson J.L., van Horne C.G., Strömberg I., Brock S., Clayton J., Masserano J., Hoffer B.J., Gerhardt G.A. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 1993, 626:167-174.
25. Inoue H., Ohsawa I., Murakami T., Kimura A., Hakamata Y., Sato Y., Kaneko T., Takahashi M., Okada T., Ozawa K., Francis J., Leone P., Kobayashi E. Development of new inbred transgenic strains of rats with LacZ or GFP. Biochem. Biophys. Res. Commun. 2005, 329:288-295.
26. Jiang W., Büchele F., Papazoglou A., Döbrössy M., Nikkhah G. Multitract Microtransplantation Increases the Yield of DARPP-32-Positive Embryonic Striatal Cells in a Rodent Model of Huntington's Disease. Cell Transplant. 2011, 20:1515-1527.
27. Jin K.L., Mao X.O., Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:10242-10247.
28. Jin K., Zhu Y., Sun Y., Mao X.O., Xie L., Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11946-11950. 10.1073/pnas.182296499.
29. Karlsson J., Emgård M., Brundin P. Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants. Brain Res. 2002, 955:268-280.
30. Klein A., Metz G.A., Papazoglou A., Nikkhah G. Differential effects on forelimb grasping behavior induced by fetal dopaminergic grafts in hemiparkinsonian rats. Neurobiol. Dis. 2007, 27:24-35.
31. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert G.M., Perl D.P. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 1995, 332:1118-1124.
32. Krause M., Ganser C., Kobayashi E., Papazoglou A., Nikkhah G. The Lewis GFP transgenic rat strain is a useful cell donor for neural transplantation. Cell Transplant. 2012, 21:1837-1851. 10.3727/096368911X627426.
33. Krum J.M., Rosenstein J.M. Patterns of angiogenesis in neural transplant models: II. Fetal neocortical transplants. J. Comp. Neurol. 1988, 271:331-345.
34. Krum J.M., Rosenstein J.M. Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds. Exp. Neurol. 1999, 160:348-360.
35. Lok J., Gupta P., Guo S., Kim W.J., Whalen M.J., Leyen K., Lo E.H. Cell-cell signaling in the neurovascular unit. Neurochem. Res. 2007, 32:2032-2045.
36. Love R.M., Branton R.L., Karlsson J., Brundin P., Clarke D.J. Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease. Cell Transplant. 2002, 11:653-662.
37. Mahalik T.J., Hahn W.E., Clayton G.H., Owens G.P. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 1994, 129:27-36.
38. Marti H.H., Risau W. Angiogenesis in ischemic disease. Thromb. Haemost. 1999, 82(Suppl. 1):44-52.
39. Maurer M.H., Tripps W.K.C., Feldmann R.E., Kuschinsky W. Expression of vascular endothelial growth factor and its receptors in rat neural stem cells. Neurosci. Lett. 2003, 344:165-168.
40. Mayhew T.M. A review of recent advances in stereology for quantifying neural structure. J. Neurocytol. 1992, 21:313-328.
41. Moses D., Drago J., Teper Y., Gantois I., Finkelstein D.I., Horne M.K. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo. Neuroscience 2008, 154:606-620.
42. Nikkhah G., Smits A., Tingström A., Othberg A., Brundin P., Funa K., Lindvall O., Odin P. Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Exp. Brain Res. 1993, 92:516-523.
43. Nikkhah G., Cunningham M.G., Jödicke A., Knappe U., Björklund A. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res. 1994, 633:133-143.
44. Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M.G., Björklund A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 1994, 63:57-72.
45. Nikkhah G., Rosenthal C., Falkenstein G., Roedter A., Papazoglou A., Brandis A. Microtransplantation of dopaminergic cell suspensions: further characterization and optimization of grafting parameters. Cell Transplant. 2009, 18:119-133.
46. Olanow C.W., Kordower J.H., Freeman T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 1996, 19:102-109.
47. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., Freeman T.B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 2003, 54:403-414.
48. Pennell N.A., Streit W.J. Colonization of neural allografts by host microglial cells: relationship to graft neovascularization. Cell Transplant. 1997, 6:221-230.
49. Piccini P., Lindvall O., Björklund A., Brundin P., Hagell P., Ceravolo R., Oertel W., Quinn N., Samuel M., Rehncrona S., Widner H., Brooks D.J. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann. Neurol. 2000, 48:689-695.
50. Raff M.C., Barres B.A., Burne J.F., Coles H.S., Ishizaki Y., Jacobson M.D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 1993, 262:695-700.
51. Roitbak T., Li L., Cunningham L.A. Neural stem/progenitor cells promote endothelial cell morphogenesis and protect endothelial cells against ischemia via HIF-1alpha-regulated VEGF signaling. J. Cereb. Blood Flow Metab. 2008, 28:1530-1542.
52. Rosenstein J.M., Krum J.M. New roles for VEGF in nervous tissue - beyond blood vessels. Exp. Neurol. 2004, 187:246-253.
53. Schierle G.S., Karlsson J., Brundin P. MK-801 does not enhance dopaminergic cell survival in embryonic nigral grafts. Neuroreport 1998, 9:1313-1316.
54. Sinclair S.R., Fawcett J.W., Dunnett S.B. Delayed implantation of nigral grafts improves survival of dopamine neurones and rate of functional recovery. Neuroreport 1999, 10:1263-1267.
55. Sortwell C.E. Strategies for the augmentation of grafted dopamine neuron survival. Front. Biosci. 2003, 8:s522-s532.
56. Sortwell C.E., Pitzer M.R., Collier T.J. Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival. Exp. Neurol. 2000, 165:268-277.
57. Steiner B., Winter C., Blumensath S., Paul G., Harnack D., Nikkhah G., Kupsch A. Survival and functional recovery of transplanted human dopaminergic neurons into hemiparkinsonian rats depend on the cannula size of the implantation instrument. J. Neurosci. Methods 2008, 169:128-134.
58. Teng H., Zhang Z.G., Wang L., Zhang R.L., Zhang L., Morris D., Gregg S.R., Wu Z., Jiang A., Lu M., Zlokovic B.V., Chopp M. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J. Cereb. Blood Flow Metab. 2008, 28:764-771.
59. Timmer M., Nikkhah G. A novel strategy for intrastriatal dopaminergic cell transplantation: Sequential "nest" grafting influences survival and behavioral recovery in a rat model of Parkinson's disease. Exp. Cell Res. 2012, 318:2531-2542.
60. Timmer M., Müller-Ostermeyer F., Kloth V., Winkler C., Grothe C., Nikkhah G. Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms. Exp. Neurol. 2004, 187:118-136.
61. Torres E.M., Monville C., Lowenstein P.R., Castro M.G., Dunnett S.B. Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age. Brain Res. Bull. 2005, 68:31-41.
62. Vesper J., Haak S., Ostertag C., Nikkhah G. Subthalamic nucleus deep brain stimulation in elderly patients - analysis of outcome and complications. BMC Neurol. 2007, 7:7.
63. Yurek D.M., Seroogy K.B. Differential expression of neurotrophin and neurotrophin receptor mRNAs in and adjacent to fetal midbrain grafts implanted into the dopamine-denervated striatum. J. Comp. Neurol. 2000, 423:462-473.
64. Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 2005, 14:207-221.